OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Reactogenicity, immunogenicity, and humoral immune response dynamics after the third dose of heterologous COVID-19 vaccines in participants fully vaccinated with inactivated vaccine
Kriangkrai Tawinprai, Taweegrit Siripongboonsitti, Thachanun Porntharukchareon, et al.
Expert Review of Vaccines (2022) Vol. 21, Iss. 12, pp. 1873-1881
Closed Access | Times Cited: 5
Kriangkrai Tawinprai, Taweegrit Siripongboonsitti, Thachanun Porntharukchareon, et al.
Expert Review of Vaccines (2022) Vol. 21, Iss. 12, pp. 1873-1881
Closed Access | Times Cited: 5
Showing 5 citing articles:
COVID-19 vaccines: A comprehensive review of safety and efficacy
Zhipeng Yan, Ming Yang, Ching‐Lung Lai
Elsevier eBooks (2025), pp. 685-777
Closed Access
Zhipeng Yan, Ming Yang, Ching‐Lung Lai
Elsevier eBooks (2025), pp. 685-777
Closed Access
COVID-19 lateral flow IgG seropositivity and serum neutralising antibody responses after primary and booster vaccinations in Chile: a cross-sectional study
Denis Sauré, Miguel O’Ryan, Juan Pablo Torres, et al.
The Lancet Microbe (2023) Vol. 4, Iss. 3, pp. e149-e158
Open Access | Times Cited: 14
Denis Sauré, Miguel O’Ryan, Juan Pablo Torres, et al.
The Lancet Microbe (2023) Vol. 4, Iss. 3, pp. e149-e158
Open Access | Times Cited: 14
Immunogenicity and reactogenicity of heterologous prime-boost vaccination with inactivated COVID-19 and ChAdOx1 nCoV-19 (AZD1222) vaccines, a quasi-experimental study
Kriangkrai Tawinprai, Pawornrath Jungsomsri, Onnicha Pinijnai, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 1
Open Access | Times Cited: 2
Kriangkrai Tawinprai, Pawornrath Jungsomsri, Onnicha Pinijnai, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 1
Open Access | Times Cited: 2
Effect of the third dose of BNT162b2 COVID-19 mRNA vaccine on anti-SARS-CoV-2 antibody levels in healthcare workers
Hidenori Tanaka, Junji Mukai, Kenichi Kushibiki, et al.
Vaccine (2022) Vol. 41, Iss. 2, pp. 365-371
Open Access | Times Cited: 3
Hidenori Tanaka, Junji Mukai, Kenichi Kushibiki, et al.
Vaccine (2022) Vol. 41, Iss. 2, pp. 365-371
Open Access | Times Cited: 3
Heterologous prime-boost with mRNA-1273 stimulates persistent neutralising antibodies in BBIBP-CorV-vaccinated individuals
Hanisah Sharif, Hazim Ghani, Liyana Ahmad, et al.
Vaccine (2023) Vol. 41, Iss. 47, pp. 6910-6913
Open Access | Times Cited: 1
Hanisah Sharif, Hazim Ghani, Liyana Ahmad, et al.
Vaccine (2023) Vol. 41, Iss. 47, pp. 6910-6913
Open Access | Times Cited: 1
